Effects of enalaprilat infusion on hemodynamics and renal function in patients undergoing cardiac surgery

Anadolu Kardiyoloji Dergisi

Volumn 4, Issue 4, 2004, Pages 296-300

  Türker, Handan ^a   Dönmez, Asli ^a   Zeyncloǧlu, Pinar ^a   Sezgin, Atilla ^a   Uluçam, Melek ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

Cardiopulmonary bypass; Enalaprilat; Hemodynamics; Renal function

Indexed keywords

CREATININE; DIAZEPAM; DOPAMINE; ENALAPRIL MALEATE; ETOMIDATE; FENTANYL; ISOFLURANE; MORPHINE SULFATE; UREA; VECURONIUM;

ADULT; ANESTHESIA INDUCTION; ARTICLE; CARDIOPULMONARY BYPASS; CENTRAL VENOUS PRESSURE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG INFUSION; ECHOCARDIOGRAPHY; FEMALE; HEART OUTPUT; HEART SURGERY; HUMAN; HYPOTENSION; KIDNEY BLOOD FLOW; KIDNEY DYSFUNCTION; MALE; MEAN ARTERIAL PRESSURE; MEDICAL RECORD; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; RANDOMIZED CONTROLLED TRIAL; RENOVASCULAR HYPERTENSION; STATISTICAL SIGNIFICANCE; SYSTEMIC VASCULAR RESISTANCE; UREA BLOOD LEVEL;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIAC OUTPUT; CARDIOPULMONARY BYPASS; CORONARY ARTERIOSCLEROSIS; CREATININE; ENALAPRILAT; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; INFUSIONS, INTRAVENOUS; KIDNEY; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; TREATMENT OUTCOME; UREA;

EID: 10644219619     PISSN: 13028723     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Mangano CM, Hill L, Cartwright CR, Hindman B. Cardiopulmonary bypass and the anesthesiologist. In: Kaplan JA, editor. Cardiac Anesthesia. Philadelphia: WB Saunders; 1999. p.1061-110.
2. Colson P, Ribstein J, Mimran A, Grolleau D, Chaptal PA, Roquefeuil B. Effect of angiotensin converting enzyme inhibition on blood pressure and renal function during open heart surgery. Anesthesiology 1990;72:23-7.
3. Bjorck S, Mulec H, Johnsen SA, Norden G, Aurell M. Renal protective effect of enalapril in diabetic nephropathy. BMJ 1992 8;304:339-43.
4. Boldt J, Schindler KF, Stertman WA, Hempelmann G. Isolated circulatory response to intravenous administration of the ACE inhibitor enalaprilat. Br J Clin Pharmac 1994;37:341-6.
5. Ryckwaert F, Colson P, Ribstein J, Boccara G, Guillon G. Haemodynamic and renal effects of intravenous enalaprilat during coronary artery bypass graft surgery in patients with ischaemic heart dysfunction. Br J Anaesth 2001;86:169-75.
6. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2: 358-67.
7. Quinones MA, Otto CM, Stoddard M, et al. Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. Recommendations for quantification of Doppler echocardiography: a report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography J Am Soc Echocardiogr 2002;15:167-84.
8. Rady MY, Ryan T. The effects of preoperative therapy with angiotensin converting enzyme inhibitors on clinical outcome after cardiovascular surgery. Chest 1998;114:487-94.
9. Bellomo R, Kellum J, Ronco C. Acute renal failure: time for consensus. Intensive Care Med 2001;27:1685-8.
10. Ryckwaert F, Boccara G, Frappier JM, Colson PH. Incidence, risk factors, and prognosis of a moderate increase in plasma creatinine early after cardiac surgery. Crit Care Med 2002;30:1495-8.
11. Mulec H, Johnsen SA, Bjorck S. Long-term enalapril treatment in diabetic nephropathy. Kidney Int Suppl 1994;45:S141-4.
12. Gottlieb SS, Weir Mr. Renal effects of angiotensin-converting enzyme inhibition in congestive heart failure. Am J Cardiol 1990;66:14D-21D.
13. Heeg JE, de Jong PE, Van Der Hem GK, de Zeeuw D. Reduction of proteinuria by angiotensin converting enzyme inhibition. Kidney Int 1987;32:78-83.
14. Boldt J, Schindler E, Wollbruck M, Gorlach G, Hempelmann G. Cardiorespiratory response of intravenous angiotensin-converting enzyme inhibitor enalaprilat in hypertensive cardiac surgery patients. J Cardiothorac Vasc Anesth 1995;9:44-9.
15. Tuman KJ, McCarthy RJ, O'Connor CJ, Holm WE, Ivankovich AD. Angiotensin-converting enzyme inhibitors increase vasoconstrictor requirements after cardiopulmonary bypass. Anesth Analg 1995;80:473-9.
16. Deakin CD, Dalrymple-Hay MJ, Jones P, Monro JL. Effects of angiotensin converting enzyme inhibitors on systemic vascular resistance and vasoconstrictor requirements during hypothermic cardiopulmonary bypass. Eur J Cardiothorac Surg 1998;13:546-50.
17. Myles PS, Olenikov I, Bujor MA, Davis BB. ACE-inhibitors, calcium antagonists and low systemic vascular resistance following cardiopulmonary bypass. A case control study. Med J Aust 1993;17:675-7.
18. Webb CM, Underwood R, Anagnostopoulos C, et al. The effect of angiotensin converting enzyme inhibition on myocardial function and blood pressure after coronary artery bypass surgery- a randomised study. Eur J Cardiothorac Surg 1998;13:42-8.
19. Boldt J, Rothe G, Schindler E. Can clonidine, enoximone, and enalaprilat help to prevent the myocardium against ischemia in cardiac surgery. Heart 1996;76:207-13.
20. Hock CE, Ribeiro LG, Lefer AM. Preservation of ischemic myocardium by a new converting enzyme inhibitor, enalaprilic acid, in acute myocardial infarction. Am Heart J 1985;109:222-8.
21. Sirivell S, Gielchinsky I, Parsonnet V. Angiotensin converting enzyme inhibitor therapy in severe postcardiotomy dysfunction: a prospective randomized study. J Card Surg 1998;13:11-7.